Table: Fuji Pharmaceutical - 6-MTH group results

Fuji Pharma

08/05/2025 08:30

May 8 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Sep 30, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.10               21.39            53.36    
                 (+12.7 pct)         (+11.2 pct)      (+15.7 pct) 
  Operating          2.31                1.44             4.85    
                 (+59.7 pct)         (-20.9 pct)      (+25.0 pct) 
  Recurring          2.21                2.17             4.68    
                 (+2.0 pct)          (-11.8 pct)      (+5.3 pct)  
  Net                1.29                4.26             3.38    
                 (-69.8 pct)        (+140.2 pct)      (-45.0 pct) 
  EPS             52.83 yen          175.15 yen       139.07 yen  
  Ann Div                             42.50 yen        45.50 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             22.50 yen        25.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T